Brief: Landos Biopharma Announces Positive Results From A Phase 1 Study Of NX-13 In Healthy Volunteers

Landos Biopharma

04/03/2021 12:07

March 4 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS BIOPHARMA ANNOUNCES POSITIVE RESULTS FROM A PHASE 1
STUDY
OF NX-13 IN HEALTHY VOLUNTEERS
    * LANDOS BIOPHARMA INC - ALL PRIMARY AND SECONDARY ENDPOINTS
IN
PHASE 1 STUDY OF NX-13 WERE MET
    * LANDOS BIOPHARMA INC - EXPECTS TO INITIATE A PHASE 1B
TRIAL OF
NX-13 IN PATIENTS WITH ULCERATIVE COLITIS (UC) LATER THIS YEAR
    * LANDOS BIOPHARMA INC - ANTICIPATES FILING AT LEAST THREE
NEW
INDS IN 2021

Source text for Eikon:  ID:nGNX66qPyw 
Further company coverage:  LABP.O 

 ((Reuters.Briefs@thomsonreuters.com;))